Additional Supporting Information may be found in the online version of this article.

hep26277-sup-0001-suppfig1.tif1468KSupplementary Figure 1. DNA profile of 29 patients with high viral load who added FTC during the first 240 weeks of the study. One subject added FTC at the discretion of the investigator, but was not eligible for FTC per study criteria.
hep26277-sup-0002-supptables.doc61KSupplementary Tables 1 and 2
hep26277-sup-0003-SuppInfo.doc61KSupplementary Information

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.